Skip to main content
Home
Type 2 Diabetes ICYMI
FULL MENU Close Menu
Home
Home
Type 2 Diabetes ICYMI
  • Clinical Edge Journal Scan
  • Clinical Topics
  • Conference Coverage
  • Expert Perspectives
  • Literature Review
  • MD-IQ

Clinical Topics

October 5, 2022

Food insecurity a growing problem for many with CVD

October 5, 2022
Fran Lowry
Fran Lowry
October 5, 2022
Type 2 Diabetes ICYMI
October 4, 2022

Balanced fat intake links with less type 2 diabetes

October 4, 2022
Marlene Busko
Marlene Busko
October 4, 2022
Type 2 Diabetes ICYMI
October 3, 2022

How to improve diagnosis of HFpEF, common in diabetes

October 3, 2022
Mitchel L. Zoler, PhD
Mitchel L. Zoler, PhD
October 3, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
September 30, 2022

Once-weekly insulin promising in phase 3 trial in type 2 diabetes

September 30, 2022
Miriam E. Tucker
Miriam E. Tucker
September 30, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
September 30, 2022

Ezetimibe-statin combo lowers liver fat in open-label trial

September 30, 2022
Sara Freeman
Sara Freeman
September 30, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
September 27, 2022

Cre8 EVO stent loses sweet spot in diabetes at 2 years: SUGAR

September 27, 2022
Patrice Wendling
Patrice Wendling
September 27, 2022
TCT: Transcatheter Cardiovascular Therapeutics
Type 2 Diabetes ICYMI
September 27, 2022

Emphasis on weight loss in new type 2 diabetes guidance

September 27, 2022
Miriam E. Tucker
Miriam E. Tucker
September 27, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
September 23, 2022

Unsure on the best T2D drug choice? Let patients decide

September 23, 2022
Mitchel L. Zoler, PhD
Mitchel L. Zoler, PhD
September 23, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
Read More

Conference Coverage

October 3, 2022

How to improve diagnosis of HFpEF, common in diabetes

October 3, 2022
Mitchel L. Zoler, PhD
Mitchel L. Zoler, PhD
October 3, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
September 30, 2022

Once-weekly insulin promising in phase 3 trial in type 2 diabetes

September 30, 2022
Miriam E. Tucker
Miriam E. Tucker
September 30, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
September 30, 2022

Ezetimibe-statin combo lowers liver fat in open-label trial

September 30, 2022
Sara Freeman
Sara Freeman
September 30, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
September 27, 2022

Cre8 EVO stent loses sweet spot in diabetes at 2 years: SUGAR

September 27, 2022
Patrice Wendling
Patrice Wendling
September 27, 2022
TCT: Transcatheter Cardiovascular Therapeutics
Type 2 Diabetes ICYMI
September 27, 2022

Emphasis on weight loss in new type 2 diabetes guidance

September 27, 2022
Miriam E. Tucker
Miriam E. Tucker
September 27, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
September 23, 2022

Unsure on the best T2D drug choice? Let patients decide

September 23, 2022
Mitchel L. Zoler, PhD
Mitchel L. Zoler, PhD
September 23, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
September 23, 2022

Early age at hysterectomy ups type 2 diabetes risk

September 23, 2022
Sara Freeman
Sara Freeman
September 23, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
September 22, 2022

Could cold exposure, especially shivering, combat type 2 diabetes?

September 22, 2022
Becky McCall
Becky McCall
September 22, 2022
EASD: European Association for the Study of Diabetes
Type 2 Diabetes ICYMI
Read More

Literature Review

June 21, 2022

What’s the best time of day to exercise? It depends on your goals

June 21, 2022
Lou Schuler
Lou Schuler
June 21, 2022
Type 2 Diabetes ICYMI
June 13, 2022

New guideline for in-hospital care of diabetes says use CGMs

June 13, 2022
Marlene Busko
Marlene Busko
June 13, 2022
ADA: American Diabetes Association
Type 2 Diabetes ICYMI
June 9, 2022

ADA updates on finerenone, SGLT2 inhibitors, and race-based eGFR

June 9, 2022
Marlene Busko 
Marlene Busko 
June 9, 2022
Type 2 Diabetes ICYMI
June 1, 2022

ADA prioritizes heart failure in patients with diabetes

June 1, 2022
Mitchel L. Zoler, PhD
Mitchel L. Zoler, PhD
June 1, 2022
ADA: American Diabetes Association
Type 2 Diabetes ICYMI
May 26, 2022

SGLT2 inhibitors as first-line therapy in type 2 diabetes?

May 26, 2022
Miriam E. Tucker
Miriam E. Tucker
May 26, 2022
Type 2 Diabetes ICYMI
Read More

MD-IQ

Diabetic Kidney Disease

Type 2 Diabetes Screening Guidelines

Alcohol and Type 2 Diabetes

Type 2 Diabetes Treatment Recommendations

More

Clinical Edge Journal Scan

September 23, 2022

Commentary: Preventing and Predicting T2D Complications, October 2022

September 23, 2022
September 23, 2022
Type 2 Diabetes ICYMI
September 16, 2022

Mean A1c and A1c variability independently predict diabetes-related complications in T2D

September 16, 2022
September 16, 2022
Type 2 Diabetes ICYMI
September 16, 2022

Long-term SGLT2 inhibitor use may lower new-onset stroke risk in T2D

September 16, 2022
September 16, 2022
Type 2 Diabetes ICYMI
September 16, 2022

Increased variability in A1c and FPG is a risk factor for severe hypoglycemia

September 16, 2022
September 16, 2022
Type 2 Diabetes ICYMI
Read More

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close
  • Clinical Edge Journal Scan
  • Clinical Topics
  • Conference Coverage
  • Expert Perspectives
  • Literature Review
  • MD-IQ

More

  • MDedge